Covered recipient · General Payments record
RACHEL K LOVE
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2023
$1,883.79
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $269.07 | 16 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $83.98 | 5 |
| Exeltis, USA Inc. | $46.37 | 3 |
| Minerva Surgical, Inc | $36.33 | 2 |
| Astellas Pharma US Inc | $34.84 | 2 |
| Organon LLC | $21.95 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $16.30 | 1 |
| Agile Therapeutics, Inc. | $15.36 | 1 |
| Hologic Sales and Service, LLC | $13.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.25 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997794125 | CMS |
| ABBVIE INC. | $16.23 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997794127 | CMS |
| ABBVIE INC. | $15.07 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997794129 | CMS |
| ABBVIE INC. | $18.53 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997794131 | CMS |
| ABBVIE INC. | $14.90 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997794133 | CMS |
| Agile Therapeutics, Inc. | $15.36 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051466453 | CMS |
| Astellas Pharma US Inc | $18.83 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034160847 | CMS |
| Astellas Pharma US Inc | $16.01 | 08/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034423139 | CMS |
| Exeltis, USA Inc. | $14.06 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002126651 | CMS |
| Exeltis, USA Inc. | $17.59 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002271261 | CMS |
| Exeltis, USA Inc. | $14.72 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002158681 | CMS |
| Hologic Sales and Service, LLC | $13.94 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1024868099 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $16.30 | 05/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060832139 | CMS |
| Minerva Surgical, Inc | $18.34 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 966514453 | CMS |
| Minerva Surgical, Inc | $17.99 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 966514447 | CMS |
| Organon LLC | $21.95 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046911277 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.